Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Two siblings both had a rare case of alopecia areata at the same time.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

FFA's causes may include environmental triggers and genetic factors.

Sunlight worsens hair loss; protect scalp.

Androgens may block hair growth signals, targeting this could treat hair loss.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

White and yellow dots indicate severe female hair loss in dark skin.